Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02855346 · ClinicalTrials.gov registry record · Phase 1
PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel
A Phase 1 study, sponsored by International Partnership for Microbicides.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT02855346 is a Phase 1 study that has completed, run by International Partnership for Microbicides. The registered enrollment target is 24 participants.
The verdict
NCT02855346, a Phase 1 study, has completed, sponsored by International Partnership for Microbicides.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
PK and Safety Study of Vaginal Ring Containing Dapivirine and Levonorgestrel
Interventions
- COMBINATION_PRODUCT 200 mg of DPV + 320 mg LNG
- COMBINATION_PRODUCT 200 mg of DPV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2017-08-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02855346
The ClinicalTrials.gov registry entry for NCT02855346 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is International Partnership for Microbicides, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 200 mg of DPV + 320 mg LNG is the first listed.
NCT02855346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02855346 about?
NCT02855346 is a clinical study titled "PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel". PK and Safety Study of Vaginal Ring Containing Dapivirine and Levonorgestrel
What is the current status of trial NCT02855346?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2017-05-03. Estimated completion is 2017-08-18.
What interventions are being tested in trial NCT02855346?
The interventions under investigation include: 200 mg of DPV + 320 mg LNG (COMBINATION_PRODUCT), 200 mg of DPV (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT02855346?
This trial is sponsored by International Partnership for Microbicides, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.